Facebook Linkedin RSS Twitter Youtube
Home 2024

DNA-based therapeutics

Ready to Fight Future Pandemics
BioPerspectives

Ready to Fight Future Pandemics

Using Oxford Nanopore’s Multi-Omic Sequencing to Optimize Plasmids and Vectors for Cell and Gene Therapies
Drug Discovery

Using Oxford Nanopore’s Multi-Omic Sequencing to Optimize Plasmids and Vectors for Cell and Gene Therapies

Andelyn Biosciences Expands AAV Curator Platform Offering
Bioprocessing

Andelyn Biosciences Expands AAV Curator Platform Offering

Single-Use Fermentor
New Products

Single-Use Fermentor

Agilent to Acquire Biovectra for $925M, Expanding CDMO Portfolio
Bioprocessing

Agilent to Acquire Biovectra for $925M, Expanding CDMO Portfolio

Base Editing Tweaks Mouse Gut Microbiome, in Scientific First
GEN Edge

Base Editing Tweaks Mouse Gut Microbiome, in Scientific First

Adapting a Replication-Competent AAV Assay for Commercial Manufacturing
Insights

Adapting a Replication-Competent AAV Assay for Commercial Manufacturing

Increased Transfection Efficiency Boosts AAV Titers for Gene Therapies by 2–4X
Bioprocessing

Increased Transfection Efficiency Boosts AAV Titers for Gene Therapies by 2–4X

pDNA Isoforms Assessed by Microfluidic Electrophoresis
Bioprocessing

pDNA Isoforms Assessed by Microfluidic Electrophoresis

Asimov Expands Lentivirus Production Portfolio with Cell Line Development Service
Bioprocessing

Asimov Expands Lentivirus Production Portfolio with Cell Line Development Service

123...12Page 1 of 12
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.